Infrastructure, capabilities, and capacities required for clinical trials design and delivery: A rapid scoping review of recommendations and regulations
Merson L. et al, (2025), Wellcome Open Research, 9, 729 - 729
Bubonic plague: can the size of buboes be accurately and consistently measured with a digital calliper?
Bourner J. et al, (2023), Trials, 24
Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19.
Camirand-Lemyre F. et al, (2023), JAMA network open, 6
A multi-country analysis of COVID-19 hospitalizations by vaccination status
Gonçalves BP. et al, (2023), Med, 4, 797 - 812.e2
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry.
Griffee MJ. et al, (2023), Research and practice in thrombosis and haemostasis, 7
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19.
Wainstein M. et al, (2023), Kidney international reports
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376
Neurological manifestations of COVID-19 in adults and children.
Cho S-M. et al, (2023), Brain : a journal of neurology, 146, 1648 - 1661
Liver injury in hospitalized patients with COVID-19: An International observational cohort study.
Tirupakuzhi Vijayaraghavan BK. et al, (2023), PloS one, 18
Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients
Baruch J. et al, (2022), Influenza and Other Respiratory Viruses, 16, 1040 - 1050
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients
Gonçalves BP. et al, (2022), eLife, 11
Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity.
Marwali EM. et al, (2022), BMJ paediatrics open, 6
Rehabilitation versus surgical reconstruction for non-acute anterior cruciate ligament injury (ACL SNNAP): a pragmatic randomised controlled trial
Beard DJ. et al, (2022), The Lancet, 400, 605 - 615
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Abbas A. et al, (2022), Scientific Data, 9
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2022), The Lancet, 399, 665 - 676
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2022), The Lancet, 399, 143 - 151
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study.
Reyes LF. et al, (2022), ERJ open research, 8, 552 - 2021
The value of open-source clinical science in pandemic response: lessons from ISARIC
Abbas A. et al, (2021), The Lancet Infectious Diseases, 21, 1623 - 1624
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort
Hall MD. et al, (2021), eLife, 10
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
Abdukahil SA. et al, (2021), Infection, 49, 889 - 905
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Abani O. et al, (2021), The Lancet, 397, 2049 - 2059
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2021), The Lancet, 397, 1637 - 1645
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abaleke E. et al, (2021), The Lancet, 397, 605 - 612
Global outbreak research: harmony not hegemony
Akhvlediani T. et al, (2020), The Lancet Infectious Diseases, 20, 770 - 772
Ethics preparedness: facilitating ethics review during outbreaks - recommendations from an expert panel
Saxena A. et al, (2019), BMC Medical Ethics, 20
Clinical REsearch During Outbreaks (CREDO) Training for Low- and Middle-Income Countries
Kayem ND. et al, (2019), Emerging Infectious Diseases, 25, 2084 - 2087
CLINICAL CHARACTERISTICS OF PATIENTS ADMITTED TO PNEUMONIC PLAGUE TREATMENT CENTERS DURING THE 2017 MADAGASCAR PNEUMONIC PLAGUE OUTBREAK: A PROSPECTIVE OBSERVATIONAL STUDY
Salam A. et al, (2018), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 99, 409 - 409
A training curriculum for conducting clinical research during outbreaks
Horby P. et al, (2017), TROPICAL MEDICINE & INTERNATIONAL HEALTH, 22, 167 - 168
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Baigent C. et al, (2011), The Lancet, 377, 2181 - 2192
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
SHARP Collaborative Group None., (2010), American Heart Journal, 160, 785 - 794.e10
Clinical Research in Resource-Limited Settings: Enhancing Research Capacity and Working Together to Make Trials Less Complicated
Lang TA. et al, (2010), PLoS Neglected Tropical Diseases, 4, e619 - e619